Clinical Trial Update: Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating cytokine-treated veto cells as an adoptive therapy after stem cell transplantation for various hematologic malignancies; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukaemia Bcr-abl1 Positive
• Follicular Lymphoma
• Hodgkin Lymphoma
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• Cytokine-Treated Veto Cells (cytokine-treated veto cells)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING